Get Free Demat Account*
Open Your Free Demat Account
Enjoy low brokerage on delivery trades
By Dalal Street Investment Journal (DSIJ)
3M India share price gained 3.46% after Q4FY26 revenue rose 16.8% YoY to ₹1,399 crore and PAT surged 201.7% YoY to ₹215 crore. FY26 PAT increased 9.7% to ₹522 crore. The board recommended a total dividend of ₹506 per share, including a final dividend of ₹160 and special dividend of ₹346.
3M India share prices jumped by 3.46% on Thursday, May 22, 2026, closing at ₹33,315, while the intra-day high was ₹34,545. It was observed that approximately 0.49 lakh shares were traded in comparison to the average deals for the last 30 days, which stood at 0.06 lakh shares. The reason behind the increase in the stock prices of 3M India is due to its earnings results along with the declaration of bumper dividends, where the final dividends were paid together for FY26.
For the quarter ended March 31, 2026, 3M India reported revenue from sales and other operating income of ₹1,399 crore, up 16.8% YoY from ₹1,198 crore in Q4FY25 and up 13.9% QoQ from ₹1,228 crore in Q3FY26. Other income for the quarter stood at ₹12 crore, compared to ₹14 crore in Q4FY25 and ₹9 crore in Q3FY26.
EBITDA for the quarter came in at ₹269 crore, up 12.2% YoY from ₹240 crore in Q4FY25 and up 12.1% QoQ from ₹240 crore in Q3FY26.
Profit before tax (PBT) stood at ₹289 crore, up 28.4% YoY from ₹225 crore in Q4FY25 and up 151.3% QoQ from ₹115 crore in Q3FY26. Net profit (PAT) for the quarter came in at ₹215 crore, up 201.7% YoY from ₹71 crore in Q4FY25 and swinging sharply into positive territory QoQ from a loss of ₹62 crore in Q3FY26. The year-on-year jump in PAT is a result of both stronger operating performance and a significantly lower base in Q4FY25, while the sequential recovery from a Q3FY26 loss to a ₹215 crore profit is the more striking data point in this quarter.
Across business segments for Q4FY26, Healthcare grew 21.3% YoY, Safety & Industrial grew 19.5% YoY, Consumer grew 15.7% YoY, and Transportation & Electronics grew 12.6% YoY — all four segments showing double-digit year-on-year growth in the quarter.
The Board of Directors, at its meeting held on May 22, 2026, recommended a total dividend of ₹506 per equity share of face value ₹10 each for the financial year 2025-26. This comprises a final dividend of ₹160 per share and a special dividend of ₹346 per share. The dividend is subject to approval by shareholders at the 39th Annual General Meeting to be held in August 2026. The record date for determining shareholder entitlement has been fixed as Friday, July 17, 2026. If approved, the dividend will be paid within 30 days from the date of the AGM.
For the full year ended March 31, 2026, 3M India posted revenue from sales and other operating income of ₹5,090 crore, up 14.5% on an annual basis from ₹4,446 crore in FY25. Other income for the year stood at ₹49 crore, compared to ₹70 crore in FY25.
EBITDA for FY26 came in at ₹1,035 crore, up 23.2% on an annual basis from ₹840 crore in FY25 — a notably faster rate of growth than the revenue increase, pointing to meaningful operating leverage through the year.
PBT for the year stood at ₹894 crore, up 15.6% on an annual basis from ₹773 crore in FY25. PAT for FY26 came in at ₹522 crore, up 9.7% on an annual basis from ₹476 crore in FY25. All four business segments delivered double-digit growth for the full year, with Healthcare leading the way and contributing most significantly to the company's overall momentum.
Aseem Joshi, Managing Director, 3M India Limited, said the company delivered 16.8% sales growth in the fourth quarter and 14.5% sales growth for the full year, both versus the prior period. He noted that for the full year FY26, all business segments grew in double digits, with Healthcare leading the company's growth. He added that the teams continued to execute well, with focus on customers and supply partners.
3M India Limited is a subsidiary of 3M Company, USA, one of the world's leading diversified technology companies. In India, the company operates across four business segments: Safety & Industrial, Transportation & Electronics, Healthcare, and Consumer. 3M India has manufacturing facilities in Ahmedabad, Bengaluru, and Pune, along with an R&D centre in Bengaluru. The company serves a wide range of industries and end markets with products spanning safety equipment, abrasives, films, oral care, wound care, filtration, and consumer goods, among others.
Source: Dalal Street Investment Journal (DSIJ), TradingView, NSE, BSE
SEBI Registered Research Analyst (INH000006396).
Founded in 1986, Dalal Street Investment Journal (DSIJ) brings decades of experience in India’s equity markets. DSIJ's research combines fundamental analysis with price action, guided by disciplined risk management and capital preservation. They follow a structured, data-driven approach designed to help investors and traders make informed decisions beyond short-term market noise.
Disclaimer :
Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes.
The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.
Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.
BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.
Content Partner - Dalal Street Investment Journal Wealth Advisory Private Limited
This article is for educational purposes only and should not be considered investment advice. Market investments are subject to risks. DSIJ Wealth Advisory Private Limited is a SEBI-registered Research Analyst (Reg. No: INH000006396) and Investment Adviser (Reg. No: INA000001142). Please consult your financial adviser before investing.
For more disclaimer, check here : https://www.bajajbroking.in/disclaimer
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading